Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday’s Mid-Day Ses

Shares of CommScope Holding Company, Inc. (NASDAQ:COMM) fell sharply during Monday’s session.

B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the price target from $2.1 to $2.

CommScope shares dipped 6.9% to $2.2150 on Monday.

Here are some other stocks moving in today's mid-day session.

Gainers

Sagimet Biosciences Inc. (NASDAQ:SGMT) shares jumped 135% to $15.99 after the company announced denifanstat in the Phase 2b FASCINATE-2 clinical trial achieved statistically significant results on the primary and multiple secondary endpoints.
Rail Vision Ltd. (NASDAQ:RVSN) surged 54.5% to $2.1173. Rail Vision said its main line system has successfully obtained formal certifications for critical European Union railway standards.
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) gained 40% to $5.36.
Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) jumped 37% to $6.70.
Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) surged 34.1% to $0.1376.
Fisker Inc. (NYSE:FSR) shares gained 32.4% to $1.0450. Fisker filed a Form 8-K with the Securities and Exchange Commission regarding amendments with its 2025 convertible notes investor.
Fitell Corporation (NASDAQ:FTEL) gained 28.5% to $2.25.
Rumble Inc. (NASDAQ:RUM) surged 25.6% to $4.51 after the company announced a partnership with Barstool Sports.
Eightco Holdings Inc. (NASDAQ:OCTO) jumped 24.9% to $0.5641.
Digital World Acquisition Corp. (NASDAQ:DWAC) rose 24% to $32.70 after Ron DeSantis ended his presidential campaign. Digital World Acquisition Corp is the business combination partner of Trump Media & Technology Group.
Fresh2 Group Limited (NASDAQ:FRES) gained 22.5% to $0.4900.
Taoping Inc. (NASDAQ:TAOP) rose 21.3% to $1.0298.
Coherus BioSciences, Inc. (NASDAQ:CHRS) shares climbed 17.1% to $2.8577 after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million upfront all cash deal.
ChargePoint Holdings, Inc. (NYSE:CHPT) rose 16.3% to $2.0250.
CXApp Inc. (NASDAQ:CXAI) gained 15% to $1.3098.
NuStar Energy L.P. (NYSE:NS) rose 14.2% to $20.59 after Sunoco announced it will acquire the company in an all-equity transaction valued at roughly $7.3 billion.
Upstart Holdings, Inc. (NASDAQ:UPST) gained 13.3% to $37.06.
Spirit Airlines, Inc. (NYSE:SAVE) climbed 12.6% to $7.53 after the company and JetBlue Airways announced Friday that they will appeal a ruling blocking their proposed merger.
Affirm Holdings, Inc. (NASDAQ:AFRM) rose 11.3% to $46.98.
Fastly, Inc. (NYSE:FSLY) gained 10.3% to $20.69 after Citigroup upgraded the stock from Sell to Neutral and raised its price target from $11 to $20.
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) gained 7% to $1.22. Aclaris Therapeutics recently announced leadership changes as the company undertakes a strategic review of its business.
Genius Group Limited (NYSE:GNS) shares gained 6.4% to $0.3110 after gaining around 9% on Friday. Genius Group recently announced closing of $8.25 million public offering.
StoneCo Ltd. (NASDAQ:STNE) rose 5.7% to $18.00. Goldman Sachs analyst Tito Labarta upgraded StoneCo from Neutral to Buy and raised the price target from $12 to $21.

Losers

Virios Therapeutics, Inc. (NASDAQ:VIRI) shares fell 39.2% to $0.4928. Virios Therapeutics announced plans to advance development of IMC-2 as treatment for symptoms associated with long-COVID.
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) fell 30.9% to $3.11. Processa Pharmaceuticals recently announced plans to expand the development of Next Generation Capecitabine into the treatment of advanced or metastatic breast cancer.
Nuvve Holding Corp. (NASDAQ:NVVE) fell 25.8% to $2.85. Nuvve recently announced a 1-for-40 reverse stock split.
Hongli Group Inc. (NASDAQ:HLP) dipped 25.7% to $2.45.
Agrify Corporation (NASDAQ:AGFY) shares fell 19.8% to $0.8495 after declining around 23% on Friday. Agrify recently entered into a multi-million dollar sales agreement with Ocean Deep/Golden Lake Business Park.
NexImmune, Inc. (NASDAQ:NEXI) declined 19.4% to $5.64.
Archer-Daniels-Midland Company (NYSE:ADM) fell 19.1% to $55.17 amid the company placing its CFO on leave due to an investigation studying accounting practices and procedures related to the company's nutrition segment. ADM said it now expects an adjusted earnings per share of $6.90 for the fiscal year ended Dec. 2023.
Calidi Biotherapeutics, Inc. (NASDAQ:CLDI) dipped 18% to $0.91
Treasure Global Inc. (NASDAQ:TGL) shares fell 17.2% to $0.0929 after gaining 9% on Friday.
MMTec, Inc. (NASDAQ:MTC) fell 14.6% to $2.09.
Intelligent Bio Solutions Inc. (NASDAQ:INBS) declined 13.4% to $0.2979. Intelligent Bio Solutions said that DGP Plc has selected the revolutionary portable intelligent fingerprinting drug screening system to enable in-house drug testing.
WiSA Technologies, Inc. (NASDAQ:WISA) shares dipped 11.7% to $0.0940 after declining over 3% on Friday.
C3is Inc. (NASDAQ:CISS) fell 11.1% to $0.1202 after falling 6% on Wednesday. C3is shares dipped 64% on Friday after the company announced pricing of its $7 million upsized underwritten public offering.
Airspan Networks Holdings Inc (NASDAQ:MIMO) declined 10.3% to $0.1895 after surging 24% on Friday. Airspan recently announced a partnership with GCT Semiconductor to develop an RF module.
B. Riley Financial, Inc. (NASDAQ:RILY) shares dipped 10.1% to $18.14. B. Riley Financial is reportedly facing a probe by U.S. authorities over its dealings with Brian Kahn, a key client linked to securities fraud, and the utilization of his assets to secure a loan from Nomura Holdings.
Gilead Sciences, Inc. (NASDAQ:GILD) fell 9.7% to $78.80 after the company reported its phase 3 study in metastatic non-small cell lung cancer did not meet primary endpoints.
e.l.f. Beauty, Inc. (NYSE:ELF) declined 6.5% to $147.62. Morgan Stanley analyst Dara Mohsenian downgraded e.l.f. Beauty from Overweight to Equal-Weight and raised the price target from $137 to $168.
Worthington Enterprises, Inc. (NYSE:WOR) fell 5% to $52.47. Goldman Sachs analyst Susan Maklari initiated coverage on Worthington Enterprises with a Sell rating and announced price target of $50.